Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Over 100,000 shares traded out of the gate

<< Previous

Bullboard Posts

Next >>

Comment by dwitzanyon Oct 18, 2021 4:19pm

254 Views

Post# 34019831

RE:RE:Over 100,000 shares traded out of the gate

Absolutely they could go there..., and take al their cash flow and gamble it against a host of established competitors with 100x their value to make a product that already exists, and would cost them 5x their current market cap just to (hopefully) develop and arrive 4-5 years late to the market..., that sound like a good idea?

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia